Roles of enhancer RNAs in sex hormone-dependent cancers

被引:1
作者
Zhang, Lu [1 ,2 ]
Ye, Xiaoxia [2 ]
Luo, Jieyi [1 ,2 ]
Chen, Jiayu [1 ,2 ]
Zheng, Weirang [1 ,2 ]
Wu, Minhua [2 ]
机构
[1] Guangdong Med Univ, Clin Med Coll 1, Zhanjiang, Peoples R China
[2] Guangdong Med Univ, Sch Basic Med, Dept Histol & Embryol, Zhanjiang, Peoples R China
关键词
Enhancer RNAs; Sex hormones; Breast cancer; Prostate cancer; Bladder cancer; Ovarian cancer; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN-RECEPTOR BINDING; THYMINE-DNA GLYCOSYLASE; POLYMERASE-II; PROSTATE-CANCER; FUNCTIONAL ROLES; REGULATED GENES; BREAST; TRANSCRIPTION; BLADDER;
D O I
10.1007/s00432-021-03886-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Enhancer RNAs (eRNAs) are non-coding RNAs, which are characterized as transcripts without protein coding functions. Increasing evidence indicates that eRNAs play important roles in gene regulation and cancer progression. Furthermore, various roles of eRNAs in sex hormone-induced signaling pathways are emerging, indicating the important roles of eRNAs in the development of sex hormone-dependent cancers. The aim of this study is to summarize the current knowledge about eRNAs in several typical sex hormone-dependent cancers, mainly involving their roles in sex hormones mediated pathways and cancer progression. Methods We reviewed all the published articles concerning eRNAs in sex hormone-dependent cancers, and summarized the roles of eRNAs in these cancers. Results In cancer development, elevated expression of some eRNAs could promote the progression of cancer cells. In gene regulation, eRNAs not only regulate gene activation but also participate in gene repression. Additionally, in androgen receptor signaling, eRNAs were found to play a role at cis and trans loci, and both sense and antisense strands of eRNAs are both important. Conclusion Abnormal overexpression of eRNAs is mostly oncogenic, leading to cancer progression, and both strands of eRNAs play multiple and complex roles at cis and trans loci in sex hormones mediated pathways, which are tightly associated with sex hormone-dependent tumorigenesis.
引用
收藏
页码:293 / 307
页数:15
相关论文
共 91 条
[1]   Molecular mechanisms and mode of tamoxifen resistance in breast cancer [J].
Ali, Shazia ;
Rasool, Mahmood ;
Chaoudhry, Hani ;
Pushparaj, Peter N. ;
Jha, Prakash ;
Hafiz, Abdul ;
Mahfooz, Maryam ;
Sami, Ghufrana Abdus ;
Kamal, Mohammad Azhar ;
Bashir, Sania ;
Ali, Ashraf ;
Jamal, Mohammad Sarwar .
BIOINFORMATION, 2016, 12 (03) :135-139
[2]   Damage-induced ubiquitylation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not Cockayne syndrome proteins or BRCA1 [J].
Anindya, Roy ;
Ayguen, Ozan ;
Svejstrup, Jesper Q. .
MOLECULAR CELL, 2007, 28 (03) :386-397
[3]   The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis [J].
Aprelikova, Olga ;
Chen, Kenny ;
El Touny, Lara H. ;
Brignatz-Guittard, Constance ;
Han, Justin ;
Qiu, Tinghu ;
Yang, Howard H. ;
Lee, Maxwell P. ;
Zhu, Min ;
Green, Jeffrey E. .
CLINICAL EPIGENETICS, 2016, 8
[4]   Sex Hormones and Prostate Cancer [J].
Auchus, Richard J. ;
Sharifi, Nima .
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020, 2020, 71 :33-45
[5]   FOXA1 represses the molecular phenotype of basal breast cancer cells [J].
Bernardo, G. M. ;
Bebek, G. ;
Ginther, C. L. ;
Sizemore, S. T. ;
Lozada, K. L. ;
Miedler, J. D. ;
Anderson, L. A. ;
Godwin, A. K. ;
Abdul-Karim, F. W. ;
Slamon, D. J. ;
Keri, R. A. .
ONCOGENE, 2013, 32 (05) :554-563
[6]   Molecular cloning of the forkhead transcription factor HNF-3 alpha from a human pulmonary adenocarcinoma cell line [J].
Bingle, CD ;
Gowan, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1996, 1307 (01) :17-20
[7]   Hypermethylation of Genes in New Long Noncoding RNA in Ovarian Tumors and Metastases: A Dual Effect [J].
Burdennyy, A. M. ;
Filippova, E. A. ;
Ivanova, N. A. ;
Lukina, S. S. ;
Pronina, I. V. ;
Loginov, V. I. ;
Fridman, M. V. ;
Kazubskaya, T. P. ;
Utkin, D. O. ;
Braga, E. A. ;
Kushlinskii, N. E. .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 171 (03) :370-374
[8]   Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update [J].
Burstein, Harold J. ;
Temin, Sarah ;
Anderson, Holly ;
Buchholz, Thomas A. ;
Davidson, Nancy E. ;
Gelmon, Karen E. ;
Giordano, Sharon H. ;
Hudis, Clifford A. ;
Rowden, Diana ;
Solky, Alexander J. ;
Stearns, Vered ;
Winer, Eric P. ;
Griggs, Jennifer J. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) :2255-+
[9]   CRISPR-Cas13a Targeting the Enhancer RNA-SMAD7e Inhibits Bladder Cancer Development Both in vitro and in vivo [J].
Che, Wenan ;
Ye, Shanting ;
Cai, Aoxiang ;
Cui, Xiaojuan ;
Sun, Yuandong .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[10]   T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor α [J].
Chen, DS ;
Lucey, MJ ;
Phoenix, F ;
Lopez-Garcia, J ;
Hart, SM ;
Losson, R ;
Buluwela, L ;
Coombes, RC ;
Chambon, P ;
Schär, P ;
Ali, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38586-38592